Experience

Global Health Innovative Technology (GHIT) Fund

• Japan
• Non-profit Organizations
• 1 - 100 Employee

• Technical Team Member

  • Apr 2020 - Present

  The Global Health Innovative Technology Fund (GHIT) is a public-private partnership fund for global health R&D. GHIT has announced the appointment of Dr. Anna-Karin Tidén (Stockholm University) as a new member of the institution’s Selection Committee (SC), which evaluates investment proposals and reports from development partners and makes investment recommendations to the Board of Directors. https://www.ghitfund.org/en The Global Health Innovative Technology Fund (GHIT) is a public-private partnership fund for global health R&D. GHIT has announced the appointment of Dr. Anna-Karin Tidén (Stockholm University) as a new member of the institution’s Selection Committee (SC), which evaluates investment proposals and reports from development partners and makes investment recommendations to the Board of Directors. https://www.ghitfund.org/en



Centre for Drug Design and Discovery

• Leuven, Belgien

• Member Of The Supervisory Board

  • Jan 2015 - Present

  CD3 is an investment fund and drug discovery center focusing on the discovery of new drugs based on innovative science from our partners. CD3 bridges the gap between innovative biomedical research emerging from academic institutes or biotechs and the pharmaceutical industry. Dr. Anna-Karin Tidén is one of the members on the Scientific Advisory Board. www.cd3.be CD3 is an investment fund and drug discovery center focusing on the discovery of new drugs based on innovative science from our partners. CD3 bridges the gap between innovative biomedical research emerging from academic institutes or biotechs and the pharmaceutical industry. Dr. Anna-Karin Tidén is one of the members on the Scientific Advisory Board. www.cd3.be



AKT Co

• Loughborough, Leicestershire, UK

• Director

  • Sep 2011 - Present

  www.aktconsultants.co.uk AKT Co is a consultancy service providing cost-effective and efficient support to R&D projects in Drug Discovery and Development. As the owner of AKT Co, I bring over 20 years of professional experience as a leader, line manager and Project Manager, with a successful track record leading multi-disciplinary research project teams and Medicinal Chemistry teams delivering on quality, on budget and to time. AKT Co can assist in the following key areas: • Project Management As a PRINCE2® Registered Practitioner AKT Co will bring clarity, vision and direction to project teams and stakeholders to support and make sure multi-disciplinary projects deliver on quality, on budget and to time. • Scientific leadership Building on experience of leading multiple projects from Hit identification to early clinical studies AKT Co can provide cross discipline leadership, as well as scientific mentorship and coaching to support the teams to achieve their goals. • Medicinal Chemistry Support a state of the art project progression based on bespoke compound criteria using project specific predictive tools. Key Optimisation Parameters will be identified and these parameters will be optimised in a parallel approach. • IP activities and co-ordination In agreement with project Patent Attorneys e.g. patent strategy, scope and medicinal chemistry example compilation will be provided. AKT Co will ensure co-ordination of project specific IP activities from Hit identification through the complete project life cycle. Basic training in IP is also on offer. • CRO Guidance and Liaison (UK, Europe and Far East) Successful leadership and co-ordination of contracts that will lead to a common goal for sponsor and CRO. • Trusted third-party assessments, supporting Due Diligence and partnership activities. AKT Co will provide independent assessments providing facts and documentation to decision makers. Show less



Stockholm University

• Sweden
• Research Services
• 700 & Above Employee

• Research Officer

  • Jan 2017 - Jul 2022

• Innovation Expert

  • Nov 2015 - Dec 2016

  As the Innovation Expert of the Berzelii Centre EXSELENT I am engaging with the scientific project teams and supporting their innovation projects with guidance in progressing these innovations through the Technology Readiness Levels. I am also responsible for IPR training for the academic members and since January 2016 also chairing the EXSELENT IPR Committee. The committee liaises with the scientists in forming their IP strategy and provide support through the process of filing a new patent application together with the chosen Patent Attorney. Show less



Ixion (part of Shaw Trust)

• Non-profit Organization Management
• 100 - 200 Employee

• European Research/Innovation Proposal Writer

  • Oct 2014 - Oct 2015



Pera Technology

• United Kingdom
• Research Services
• 1 - 100 Employee

• Proposal Writer

  • Mar 2014 - Sep 2014

  As a writer I liaise with the client to discuss their idea and/or project. Currently the focus is on the Horizon2020 funding scheme but Technology Strategy Board (TSB) and Wellcome Trust funding are often targeted. The aim of the interaction is to provide support in e.g. finding the most appropriate funding scheme and topic, identifying opportunities as well as adding value in potential partnerships. The proposal is written interactively with the client to produce a quality document which affords the best circumstances to achieve funding. Show less



AstraZeneca R&D, Charnwood, UK

• Associate Director

  • May 2007 - Aug 2011

  Manage a section comprising of 30 scientists, in three teams, involved in all aspects of Lead Identification and Lead Optimisation in both oral and inhaled projects in Respiratory and Inflammation. The section was responsible for the Medicinal Chemistry of up to six projects at any time. Accountabilities were e.g. Project Leadership, Synthetic Chemistry, Medicinal Chemistry, CRO co-ordination, IP and cross-functional partnerships both internal and external.

• Project Leader LO and Early Development

  • May 2007 - Aug 2011



AstraZeneca R&D, Södertälje, Sweden

• Associate Director

  • 2002 - 2007

  Manage a section comprising of 30 scientists involved in all aspects of Lead Optimisation in CNS and Pain Control. The section was responsible for the Medicinal Chemistry of up to five projects at any time. Accountabilities were e.g. Synthetic Chemistry, Medicinal Chemistry, CRO co-ordination, IP and cross-functional partnerships both internal and external. Manage a section comprising of 30 scientists involved in all aspects of Lead Optimisation in CNS and Pain Control. The section was responsible for the Medicinal Chemistry of up to five projects at any time. Accountabilities were e.g. Synthetic Chemistry, Medicinal Chemistry, CRO co-ordination, IP and cross-functional partnerships both internal and external.